Sophie R. Vaccarino, MD, MSc

Sophie R. Vaccarino, MD, MSc is affiliated with Cumming School of Medicine, University of Calgary, Alberta, Canada. Sophie R. Vaccarino has authored or co-authored 4 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2019 and 2024. Their work focuses on Depression (MDD), Cognition, COVID, and Electroconvulsive Therapy.

Depression (MDD) Cognition COVID Electroconvulsive Therapy

Frequent co-authors

Shane J. McInerney Sidney H. Kennedy Venkat Bhat Anthony L. Vaccarino Fathima Adamsahib Karim S. Ladha Michelle J. Blumberg Pierre Blier
JCP
Cognitive Effects of ECT in Schizophrenia: A Review
Review Article

June 5, 2024

ECT was not associated with any significant cognitive deficits in people with treatment-resistant schizophrenia across global cognition, attention, language, visuospatial function, and executive function domains. The majority of studies...
,
JCP
Systematic Review

January 4, 2022

The cognitive effects of ketamine have not been thoroughly investigated in depressed populations. This systematic review sought to determine the objective neurocognitive effects of ketamine in individuals with unipolar...
, , , et al
JCP
Original Research

July 21, 2020

What is the efficacy of antidepressants and other agents for treating cognitive impairment in adults with major depressive disorder? Review available research in this CME journal activity.
, ,
JCP
Review Article

October 8, 2019

Depression can cause notable cognitive deficits. Read this review article to learn about the efficacy of the wakefulness-promoting drug modafinil in the treatment of cognitive impairments associated with major...
, , , et al

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe